Epstein-Barr Virus-Associated Cancers: From Pathogenesis to Treatment (2nd Edition)
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Infectious Agents and Cancer".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 383
Special Issue Editor
Interests: molecular genetics of nasopharyngeal carcinoma (NPC); NPC genomics; roles of EBV in NPC tumorigenesis; new therapeutic approaches for NPC; tumor microenvironment and cancer stem-like cells in NPC
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is the second edition of the Special Issue Epstein-Barr Virus-Associated Cancers: From Pathogenesis to Treatment.
After almost 60 years of research on the Epstein–Barr virus (EBV), we are still grappling with its precise role in oncogenesis and with the ways in which this can be exploited to improve the clinical management of EBV-associated cancers. There is still much to learn about the natural history of EBV infection and how the virus interacts with different risk factors to drive the development of cancer. This Special Issue aims at providing an up-to-date assessment of the current status of our understanding of EBV’s contribution to virus-associated lymphomas and carcinomas and of the ways in which this knowledge impacts the diagnosis and treatment of these cancers. Original research articles and reviews are welcome. Research areas may include (but are not limited to) the following: (i) the role of EBV in the development of different tumours, including the contribution of EBV latent and lytic proteins; (ii) the interaction of different co-factors and the ways in which these work in concert with EBV to drive oncogenesis; (iii) the impact of EBV on the tumour microenvironment; (iv) the use of EBV as a biomarker in tumour diagnosis and prognosis; (v) current and future approaches to treating EBV-associated cancers, including immunotherapy and the targeting of individual EBV proteins; and (vi) the potential of both prophylactic and therapeutic vaccination.
I look forward to receiving your contributions.
Prof. Dr. Kwok-Wai Lo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- EBV
- lymphomas
- Burkitt lymphoma
- Hodgkin lymphoma
- NK/T cell lymphoma
- nasopharyngeal carcinoma
- gastric cancer
- biomarkers
- immunotherapy
- targeted therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
